Kathy Provost

📊 Connecticut Hiring Trends – What We're Seeing in May 2025 As someone involved in the staffing space here in Connecticut, I wanted to share a quick snapshot of the trends we’re watching closely this spring: ✅ Job Growth vs. Talent Gaps: With 73,000+ open jobs and low unemployment (3.0%), companies are competing hard for skilled talent. 🏥 Healthcare is hurting: Workforce shortages continue to strain hospitals and providers — we’re seeing rising demand for nurses, allied health, and support staff. 🏭 Manufacturing is hiring: CNC machinists, robotics techs, and QA roles are hot, but many employers are struggling to find qualified candidates. 🧠 Skills-based hiring is accelerating: More companies are rethinking degree requirements and focusing on technical competencies and soft skills. 🤖 AI is changing the game: From recruitment automation to analytics, hiring is becoming faster and more data-driven. 💡 Retention is the new recruitment: Flexible schedules, wellness initiatives, and mental health support are no longer perks — they’re expected. At Randstad, we’re working daily with employers across CT to help them adapt to these shifts — whether it’s building a more agile workforce or rethinking how they hire. If you’re navigating similar challenges, let’s connect. #Staffing #ConnecticutJobs #WorkforceTrends #Hiring2025 #RecruitmentStrategy #CTWorkforce #SkillsGap

13

Inside BioFire🔥- Culture, Growth and the Rocket Ship ride with Rachel Jones This week on Diagnosing Dx, I’m joined by Rachel Jones, former Chief Commercial Officer at BioFire Diagnostics, LLC and now at VedaBio. Rachel shares her remarkable journey from bench scientist to helping rebrand Idaho Technology into BioFire, scaling its commercial team from just 12 people into a billion-dollar diagnostics powerhouse, and ultimately shaping one of the most iconic success stories in infectious disease diagnostics.   We dig into the culture, growth, and lessons that defined BioFire’s rise, and what it takes to balance scientific innovation with commercial execution in a fast-changing market.   🔥What You’ll Learn: • How Rachel transitioned from the lab to commercial leadership • Why integrating science and business is key to scaling diagnostics • The pivotal role of syndromic testing in BioFire’s success • Lessons from BioFire’s acquisition by BioMérieux and its cultural impact 🎧 Listen/watch now on: 🔹 YouTube: https://lnkd.in/erTTpRNg 🔹 Spotify: https://lnkd.in/evmmVKgy 🔹 Apple Podcasts: https://lnkd.in/essCivJp 🔔 If you want to be alerted of new Diagnosing Dx episodes straight to your email inbox sign up here: https://lnkd.in/eQ4cebZv

95

28 Comments

Searchends Rx Chem Services is a specialized Talent Acquisition Company dedicated to the Pharmaceutical and Chemical industries. With deep domain expertise and a strong understanding of industry-specific talent requirements, we partner with organizations to identify, attract, and secure high-caliber professionals across all functional areas. Our Industry Focus includes the full value chain of the Pharmaceutical and Chemical sectors: - Active Pharmaceutical Ingredients (API) - Formulations & Finished Dosage - Specialty Chemicals - Bulk Chemicals - Agrochemicals - Petrochemicals - Biotechnology - Research & Development - Contract Manufacturing (CMO/CDMO) We understand regulatory environments such as USFDA, MHRA, EMA, WHO-GMP, and other global compliance standards that influence hiring decisions in these sectors. Our Core Recruitment Expertise encompasses: 1. **Executive & Leadership Hiring**: We assist organizations in recruiting senior leadership professionals including Plant Heads, Site Directors, R&D Heads, QA/QC Leaders, Regulatory Affairs Heads, Operations Directors, and Business Development Leaders. 2. **Technical & Functional Hiring**: We specialize in identifying technically sound professionals in Production & Manufacturing, Quality Assurance & Quality Control, Regulatory Affairs, Research & Development, Engineering & Maintenance, EHS (Environment, Health & Safety), Supply Chain & Procurement, Validation & Compliance, Process Engineering, and Analytical Development. 3. **Lateral & Volume Hiring**: We manage structured hiring programs for Greenfield projects, plant expansions, new product launches, technology transfers, and audit-driven replacement hiring. Our Strengths include: - **Deep Industry Understanding**: We evaluate candidates based on regulatory exposure, audit readiness, technical depth, process knowledge, scale of operations handled, and compliance history. - **Strong Talent Network**: We maintain an extensive database of pre-screened professionals across various levels, from shop-floor specialists to C-suite executives. - **Consultative Approach**: We act as talent advisors, employing detailed requirement mapping, competency-based screening, reference validation, cultural fit assessment, and confidential search Thanks in advance looking for a Sustainable Partnering!!!

10

TA/Recruiter job openings in the U.S. continue to climb (surprisingly!) For the first time in nearly three years, postings are holding steady above the 45,000 mark. The sharpest demand we’re seeing is from clients in Data Centers, AI, Aerospace Engineering, and VC-backed and pre-IPO tech. What’s especially interesting: this strength in TA roles is happening at the same time overall U.S. job openings are trending down (per the latest JOLTs report). August’s jobs report showed just 22K new jobs created nationwide, yet demand for recruiters is starting to surge. Why? My hunch: - Lowering interest rates are fueling capital expenditures in tech - IPO activity is picking up - VC funding is flowing again - Companies are positioning for broad hiring in tech Recruiting is often the “canary in the coal mine” for hiring cycles. If this momentum holds, it could signal a broader acceleration in tech hiring heading into 2026. 👉 Do you think this trend continues?

51

5 Comments

RoukenBio and AVS Bio Partner to De-Risk Antibody Development! Preclinical CRO RoukenBio has entered a strategic partnership with Connecticut-based biologics discovery specialist AVS Bio to strengthen therapeutic antibody development and reduce late-stage trial failures. The collaboration will integrate AVS Bio’s antibody discovery and computational expertise — including B-cell technologies and hybridoma generation — with RoukenBio’s advanced immunology assays that assess downstream signaling, pathway modulation, and immune cell responses. By combining high-quality antibody generation with early, mechanism-driven functional characterization, the companies aim to improve candidate selection from discovery through preclinical and IND-enabling studies. The partnership reflects a growing industry emphasis on embedding deeper biological insight earlier in the development process to improve translational success.

46

3 Comments

Boost your hiring success with these recruiting tips. Learn how to attract top talent, create a positive candidate experience, and build a stronger employer brand to find the right fit for your team.

2